Emalex Biosciences
Meredith Sattler Miller is a seasoned professional in clinical operations with extensive experience in managing clinical studies across various therapeutic areas. Currently serving as Director of Clinical Operations at Emalex Biosciences, a position held since December 2018, Meredith has previously held roles including Associate Director and Clinical Operations Manager at the same company. Prior experience includes significant contributions at Astellas Pharma and Takeda Global Research and Development, overseeing large-scale Phase III and IV clinical trials for conditions such as prostate cancer, major depressive disorder, and women's health. Meredith’s comprehensive skill set includes protocol development, vendor management, timeline adherence, and regulatory compliance, complemented by a Bachelor of Science in Biology from Indiana University Bloomington.
This person is not in any offices
Emalex Biosciences
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.